Provider Profile:
Melissa Runge-Morris, M.D.
Back to Results
Are you the Physician? Update Profile
Melissa Runge-Morris, M.D.
Specialties
Oncology - Hematology, Oncology - Medical
Subspecialties
Malignant Hematology, Bone Marrow Transplant
Board Certification
American Board of Internal Medicine - Medical Oncology
Multidisciplinary Team
Hematology Oncology
Locations
Karmanos Cancer Center
4100 John R
Detroit, MI 48201
Get Directions
Phone:
1-800-KARMANOS
Call For Appointment
Watch Video
Cancers Treated
Locations
Education
Additional Info
Awards
Publications
Cancers Treatments
Cancers Treated
Back to top
Hodgkin Lymphoma
Leukemia
Lymphoma
Multiple Myeloma
Myelodysplasia (MDS)
Non-Hodgkin Lymphoma
Plasmacytoma
Locations
Locations
Back to top
Karmanos Cancer Center
4100 John R
Detroit, MI 48201
Get Directions
Phone:
1-800-KARMANOS
Get Directions
Get Directions
Get Directions
Get Directions
Education
Education
Back to top
School
University of Michigan
Residency
Internal Medicine, Hennepin County Hospital, Minneapolis, Minnesota
Fellowships
Fellowship Hematology-Oncology, Northwestern University, Chicago, IL, Postdoctoral Fellow, NIH Physician Scientist Award, Dept. of Pharmacology, Northwestern University
Additional Info
Additional Info
Back to top
Awards
Awards
Back to top
Awards
2006 Wayne State University School of Medicine, Faculty Research Excellence Award
2004 Wayne State University School of Medicine, College Teaching Award
1987-1992 Physician Scientist Training Award, National Institutes of Environmental Health Sciences Grant Number: K11 - ES 00170
1986-1987 National Institute of Health Neuroscience Toxicology Fellowship, National Institutes of Health Training Grant T32 NS07140, Department of Pharmacology, Northwestern University
Professional Memberships
International Society for the Study of Xenobiotics (ISSX)
American Association for Cancer Research (ACCR)
American Society for Biochemistry and Molecular Biology (ASBMB)
American Society of Clinical Oncology (ASCO)
American Society of Hematology (ASH) American Society for Pharmacology and Experimental Therapeutics
Publications
Publications
Back to top
The Kinetics of Sterol Sulfonation by Sulfotransferases: Implications for Nuclear Receptor Activation, in preparation. Authors: I. Cook, Z. Duniec-Dmuchowski, T.A. Kocarek, M. Runge-Morris and C.N. Falany (2012).
Site-Directed Mutagenesis of Human Cytosolic Sulfotransferase (SULT)2B1b to Phospho-Mimetic Ser348Asp Results in an Isoform with Increased Catalytic Activity. J. Steroid Biochem. Mol. Bio., 127: 315-323. Authors: E.D. Salman, D. He, M. Runge-Morris, T.A. Kocarek, and C.N. Falany (2011)
Regulation of SULT1E1 Expression by Confluency of MCF10A Breast Epithelial Cells: Role of the Aryl Hydrocarbon Receptor. J. Pharmacol. Exp. Ther., 339: 597-606. Authors: J. Fu, H. Fang, M. Paulsen, M. Ljungman, T.A. Kocarek and M. Runge-Morris (2011)
Sulfation of 25-Hydroxycholesterol by SULT2B1b Decreases Cellular Lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells. Atherosclerosis 214: 350-356. Authors: Q. Bai, L. Xu, L., G. Kakiyama, M.A. Runge-Morris, P.B. Hylemon, L. Yin, W.M. Pandak, and S. Ren, (2011)
Expression of Estrogenicity Genes in a Lineage Cell Culture Model of Human Breast Cancer Progression. Breast Cancer Res. Treat., 120: 35-45. Authors: J. Fu, A.M. Weise, J. L. Falany, C.N. Falany, B.J. Thibodeau, F.R.Miller, T.A. Kocarek and M. Runge-Morris (2010)
Loading...